Over the past decade, the second-to-fourth digit ratio (2D:4D), a putative biomarker for the organizational (permanent) effects of prenatal androgens on the human brain, body, and behavior, has received extensive research attention in psychology. This account makes more widely accessible the contributions of the German psychologist, Hans-Dieter Rösler, an early, for a long time unnoticed, predecessor of modern 2D:4D research. In the mid-1950s, Rösler collected a massive sample of hand outline drawings, totalling nearly 7,000 individuals, ranging in age from 1 mo. to 70 yr. With regard to the distal finger-extent pattern, Rösler differentiated radial (longer index than ring finger), ulnar (reversed pattern), and intermediate hand types, which reflect higher (more female-typical), lower (more male-typical), and intermediate 2D:4D, respectively. Here is summarized Rösler's research. In a series of investigations into the hand types, he reported on their anatomical bases, unsuitability for paternity testing, developmental changes, heritability, sex, side, and occupational group differences, and associations with left-handedness, manual dexterity, mental retardation, and clinodactyly. Based on new data from 313 male and 316 female adults, hand type is further shown to be only a weak proxy of actual 2D:4D, leaving 75% of the interindividual variation in 2D:4D unexplained. Notwithstanding these shortcomings of the hand-type method, Rösler's work from the 1950s still has the potential to inform modern 2D:4D research, as it contains a multitude of testable hypotheses not yet picked up by current research.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2466/pr0.103.3.899-916 | DOI Listing |
JAMA
December 2024
Hcor Research Institute, São Paulo, Brazil.
Importance: High-flow nasal oxygen (HFNO) and noninvasive ventilation (NIV) are commonly used respiratory support therapies for patients with acute respiratory failure (ARF).
Objective: To assess whether HFNO is noninferior to NIV on the rates of endotracheal intubation or death at 7 days in 5 patient groups with ARF.
Design, Setting, And Participants: This noninferiority, randomized clinical trial enrolled hospitalized adults (aged ≥18 years; classified as 5 patient groups with ARF: nonimmunocompromised with hypoxemia, immunocompromised with hypoxemia, chronic obstructive pulmonary disease [COPD] exacerbation with respiratory acidosis, acute cardiogenic pulmonary edema [ACPE], or hypoxemic COVID-19, which was added as a separate group on June 26, 2023) at 33 hospitals in Brazil between November 2019 and November 2023 (final follow-up: April 26, 2024).
Br J Anaesth
November 2024
Instituto de Pesquisa Hcor, São Paulo, Brazil; Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil; Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, and Alberta Health Service, Edmonton, AB, Canada. Electronic address:
Background: This study aimed to assess whether a driving pressure-limiting strategy based on positive end-expiratory pressure (PEEP) titration according to best respiratory system compliance and tidal volume adjustment increases the number of ventilator-free days within 28 days in patients with moderate to severe acute respiratory distress syndrome (ARDS).
Methods: This is a multi-centre, randomised trial, enrolling adults with moderate to severe ARDS secondary to community-acquired pneumonia. Patients were randomised to a driving pressure-limiting strategy or low PEEP strategy based on a PEEP:FiO table.
Braz J Cardiovasc Surg
October 2024
Hospital Regional Hans Dieter Schmidt, Joinville, Santa Catarina, Brazil.
Cardiovasc Revasc Med
September 2024
Department of Interventional Cardiology, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Background: Transcatheter aortic valve implantation (TAVI) is a well-established treatment for symptomatic patients with aortic stenosis. Yet, the impact of sex differences and public vs. private procedural setting on TAVI outcomes remain uncertain.
View Article and Find Full Text PDFMicroorganisms
August 2024
RedHill Biopharma Ltd., Tel-Aviv 6473921, Israel.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!